Trial no.:
|
PACTR202009722252659 |
Date of Approval:
|
15/09/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Efficacy of strain counter strain technique on electromyographic amplitude in subjects with upper trapezius trigger points. Randomized clinical trials |
Official scientific title |
Efficacy of strain counter strain technique on electromyographic amplitude, pain, and function in subjects with upper trapezius trigger points. Randomized clinical trials |
Brief summary describing the background
and objectives of the trial
|
myofascial pain syndrome is one of the common musculoskeletal pain disorders which affects almost 95% of people with chronic pain disorders and is a common finding in specially pain management Centre.It is characterized by trigger points, which are defined as hyperirritable spots within taut bands of skeletal muscle fibers. The syndrome is associated with tenderness in the muscle, referred pain, spasm and restriction of motion (Simons et al 1999). From different treatment methods on the Myo-fascial trigger points, Strain counterstrainis one of the treatment approaches whose effectiveness need an evaluation on scientific grounds. It is an osteopathic technique used by physical therapists and osteopaths, defined as ―the passive specific positioning of patient and affected region by the physical therapist for 90 seconds that would reduce the sensitivity of trigger point‖. The specific positioning of the upper trapezius is ipsilateral side flexion, contralateral rotation, ipsila-teral shoulder abduction and external rotation. The position is maintained for 90 seconds. In the present prospect and knowledge found in some databases i.e. PUBMED, Google Scholar, CIN-HAL and DOAJ, there is hardly any study found in the region addressing the effectiveness of strain counter-strain on muscle amplitude in subjects with upper trapezius trigger points, so this study was conducted. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
SCS |
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/10/2020 |
Actual trial start date |
12/10/2020 |
Anticipated date of last follow up |
30/12/2020 |
Actual Last follow-up date |
30/12/2020 |
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
40 |
Recruitment status |
Completed |
Publication URL |
|
|